A prospective, multicenter, randomized controlled study of Mohs microsurgery versus wide local resection in treating sebaceous cell carcinoma

A study of Mohs microsurgery versus wide local resection in treating sebaceous cell carcinoma

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-15006458

Enrollment

Unknown

Registered

2015-05-28

Start date

2015-06-10

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sebaceous cell carcinoma

Interventions

wide local resection :wide local resection

Mohs microsurgery :Mohs microsurgery

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) 18 Years to 90, both gender; (2) Sebaceous cell carcinoma patients before stage IIIA; (3) be willing to take part in the clinical trial and sign the informed consent form; (4) be willing to have these tumor sites surgically removed and do the follow up accordingly.

Exclusion criteria

Exclusion criteria: (1) Without pathological diagnosed SCC; (2) Sebaceous cell carcinoma patients after stage IIIB; (3) Has abnormal cardiovascular, hepatic, renal function; (4) Has other abnormal eye diseases; (5) not willing to take part in the clinical trial; (6) not willing to do the follow up accordingly or the duration of follow up is less than 2 years; (7) Menstrual, pregnancy or breast-feeding; (8) Tumor growth with discontinuous pattern; (9) sebaceous cell carcinoma that has been previously treated; (10) Took part in other clinical trials within three months.

Design outcomes

Primary

Measure	Time frame
survival rate;recurrence rate;cure rate;metastasis rate;	—

Countries

China

Contacts

Public ContactFan Xianqun

fanxq@sh163.net+86 13818567505

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026